Brain's Immune Cells Caught Eating Healthy Neurons in Parkinson's Disease

A Case of Mistaken Identity Inside the Brain

Parkinson's disease has long been associated with the progressive loss of dopamine-producing neurons in a brain region called the substantia nigra. Now, researchers at the Institut de Neurociencies of the Universitat Autonoma de Barcelona have uncovered a startling mechanism: the brain's own immune cells are actively and mistakenly destroying healthy neurons.

The study, published in npj Parkinson's Disease, reveals that microglia, the brain's resident immune cells, overexpress receptors known as Fc gamma receptors (specifically CD16 and CD32) in the brains of Parkinson's patients. These receptors normally help identify damaged or dying cells for removal. However, in Parkinson's disease, they appear to misidentify still-functional dopaminergic neurons as waste, triggering a process called phagocytosis where the microglia physically engulf and destroy the neurons.

How the Destruction Unfolds

The research team, led by Carlos Barcia, examined postmortem brain tissue from Parkinson's patients and found elevated levels of these Fc gamma receptors on reactive microglia in the substantia nigra. When activated, the receptors trigger a protein called Cdc42, which causes the microglia to reshape themselves and form structures capable of swallowing neurons whole.

Prior work from the same team had already shown that microglia make direct physical contact with vulnerable neurons before they disappear, suggesting active destruction rather than the passive degeneration previously assumed.

Immunotherapy Offers Protection

The most promising finding is therapeutic. In both cell cultures and the MPTP mouse model of Parkinson's disease, blocking Fc gamma receptors with neutralising antibodies significantly reduced the elimination of dopaminergic neurons. Even under conditions of intense neuroinflammation, the neurons were preserved.

Pharmacologically inhibiting Cdc42 produced similar protective results, offering a second potential therapeutic pathway.

A Different Approach to Treatment

While the research remains preclinical, it represents a fundamentally different strategy to existing approaches. Rather than attempting to rescue neurons after degeneration has begun, this approach aims to prevent the immune system from destroying them in the first place. With Parkinson's disease affecting millions worldwide and global cases projected to reach over twenty five million by twenty fifty, new therapeutic avenues are urgently needed.